Alvotech (ALVO) Non-Current Deferred Tax Liability (2020 - 2025)
Alvotech (ALVO) reported Non-Current Deferred Tax Liability of $7.9 million for Q4 2025, up 334.46% on a YoY basis from $1.8 million in Q4 2024, and up 4.36% quarter-over-quarter from $7.5 million in Q3 2025.
Alvotech (ALVO) Non-Current Deferred Tax Liability (2020 - 2025) Analysis & Trends
Alvotech has reported Non-Current Deferred Tax Liability for 6 years, with the latest figure at $7.9 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Deferred Tax Liability rose 334.46% year-over-year to $7.9 million; the trailing twelve-month figure through Dec 2025 stood at $7.9 million (up 334.46% YoY), and the FY2025 full-year result was $7.9 million, up 334.46% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2025 stood at $7.9 million, up from $7.5 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $7.9 million in Q4 2025, with the low at $45000.0 in Q2 2023.
- Historically, Non-Current Deferred Tax Liability has averaged $1.9 million across 5 years, with a median of $1.5 million in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability plunged 82.85% — and 2024, when it soared 3316.98%.
- Alvotech's Non-Current Deferred Tax Liability stood at $150000.0 in 2021, then surged by 106.0% to $309000.0 in 2022, then sank by 82.85% to $53000.0 in 2023, then soared by 3316.98% to $1.8 million in 2024, then soared by 334.46% to $7.9 million in 2025.
- The last three Non-Current Deferred Tax Liability figures came in at $7.9 million (Q4 2025), $7.5 million (Q3 2025), and $2.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Alvotech | 12.16 Mn | -160.20 Mn | -22.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.87 Mn |
| Dec 31, 2025 | 7.87 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 53,000.00 |
| Dec 31, 2023 | 53,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Jun 30, 2023 | 45,000.00 |